Price Transparencybeta Hospital negotiated rates

Hospital facility prices. What the hospital charges for the facility side of care — the surgeon’s and anesthesiologist’s fees are billed separately and are not included. How we scope prices →

Export CSV

JACKSON COUNTY REGIONAL HEALTH CENTER

Maquoketa, IA · CCN 161329 · Rates published

5,001 distinct procedures filed
21 distinct payers
431,549 rate rows
2026-08-11 last MRF observed

407,010 of 431,549 rate rows are consumer-grade (94.3%)

24,539 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.

Excluded — reasonRows
no usable negotiated amount (only an out-of-band fallback) — excluded from medians 23,447
placeholder amount (≤ $0.02) — excluded from medians 531
exceeds 10× this hospital's gross charge — excluded from medians 446
below 25% of the Medicare reference for this code — likely a mislabeled per-diem or placeholder; excluded from medians 57
percent-of-charges filed in the dollar field — excluded from medians 51
per-diem day rate — not a per-procedure price 7
↓ Download audit trail (JSON)
Source MRF file https://jcrhc.org/wp-content/uploads/426037868_jackson-county-regional-health-center_standardcharges.csv
Found on page https://jcrhc.org/price-transparency/
Discovered viaDiscovered by HANK
Last fetch not_modified · 2026-10-20
Content fingerprint 3882ea80782532e1… · 89,636,511 bytes · first seen 2026-05-08

Top 50 most expensive offerings

Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.

Code Description Payers Min $ Max $ Avg median vs national
Q2043
HCPCS
Sipuleucel-t - Su 19 $48,124.17 $164,685.45 $93,378.35 nat. median
$65,448

1.4× median
J9347
HCPCS
Tremelimumab Actl 300 Mg/15 Ml Inj 18 $51,590.29 $115,093.32 $86,397.75 nat. median
$3,185

outlier · 27.1×
J9359
HCPCS
Loncastuximab Tesirine 10 Mg Inj 18 $33,787.74 $75,377.44 $56,584.01 nat. median
$727

outlier · 77.8×
J3357
HCPCS
Ustekinumab 90 Mg/ml Syringe 21 $180.12 $78,207.73 $34,044.55 nat. median
$15,290

outlier · 2.2×
J9266
HCPCS
Pegaspargase 750 I-units/ml Inj 5 Ml 21 $17,834.97 $71,803.25 $33,184.21 nat. median
$33,233

1.0× median
J9298
HCPCS
Nivolumab-relatlimab Rmbw 240 Mg-80 Mg/20 Ml 18 $18,866.63 $42,089.76 $31,595.76 nat. median
$555

outlier · 56.9×
J2350
HCPCS
Ocrelizumab 30 Mg/ml Inj 10 Ml 21 $57.32 $52,509.49 $28,906.23 nat. median
$725

outlier · 39.9×
J2327
HCPCS
Risankizumab 150 Mg/ml So 18 $12,583.90 $58,204.14 $26,401.88 nat. median
$2,614

outlier · 10.1×
J9272
HCPCS
Dostarlimab-gxly 500 Mg/10 Ml Inj 18 $14,724.15 $32,848.26 $24,658.39 nat. median
$775

outlier · 31.8×
0238T
OTHER
Trluml Perip Athrc Iliac Art 0238t 16 $15,325.60 $31,764.59 $24,560.25 nat. median
$17,594

1.4× median
J9043
HCPCS
Cabazitaxel 10 Mg/ml Inj 21 $196.60 $40,973.82 $22,555.90 nat. median
$742

outlier · 30.4×
J9228
HCPCS
Ipilimumab 5 Mg/ml Inj 40 Ml 21 $173.35 $98,755.91 $21,539.76 nat. median
$9,021

outlier · 2.4×
J1440
HCPCS
Fecal Microbiota Live-jslm Susp 18 $11,905.66 $26,560.47 $19,938.30 nat. median
$107

outlier · 187.0×
J1932
HCPCS
Lanreotide 120 Mg/0.5 Ml Inj 18 $11,765.68 $26,248.18 $19,703.87 nat. median
$113

outlier · 174.9×
J9316
HCPCS
Pertuzumab/trastuzumab/hyaluronidase 600 Mg-600 Mg-20k Units/10 20 $83.25 $37,546.24 $19,427.16 nat. median
$422

outlier · 46.1×
J9042
HCPCS
Brentuximab 5 Mg/ml Inj 21 $183.89 $32,151.90 $17,699.47 nat. median
$1,034

outlier · 17.1×
J9022
HCPCS
Atezolizumab 60 Mg/ml Inj 14 Ml 21 $87.18 $30,566.83 $16,555.34 nat. median
$7,301

outlier · 2.3×
J1303
HCPCS
Ravulizumab Cwvz 1100 Mg/11 Ml Inj 21 $226.18 $69,323.46 $16,503.92 nat. median
$6,356

outlier · 2.6×
J9119
HCPCS
Cemiplimab-rwlc 50 Mg/ml Inj 7 Ml 21 $28.48 $29,556.11 $16,270.51 nat. median
$93

outlier · 175.8×
J9307
HCPCS
Pralatrexate 20 Mg/ml Inj 21 $329.73 $36,884.79 $16,086.31 nat. median
$920

outlier · 17.5×
J9273
HCPCS
Tisotumab Vedotin Tftv 40 Mg Inj 18 $8,755.02 $19,531.66 $14,661.94 nat. median
$582

outlier · 25.2×
J9144
HCPCS
Daratumumab-hyaluronidase 1800 Mg/15 Ml 20 $49.64 $25,804.72 $14,347.43 nat. median
$233

outlier · 61.7×
J2506
HCPCS
Pegfilgrastim 6 Mg/0.6 Ml Inj 18 $8,494.08 $18,949.54 $14,224.96 nat. median
$1,685

outlier · 8.4×
J3380
HCPCS
Vedolizumab 60 Mg/ml Inj 5 Ml 21 $20.61 $24,163.19 $13,301.73 nat. median
$205

outlier · 64.8×
J1930
HCPCS
Lanreotide 90 Mg/0.3 Ml Inj 21 $64.68 $28,222.30 $12,734.99 nat. median
$5,242

outlier · 2.4×
J9301
HCPCS
Obinutuzumab 25 Mg/ml Inj 40 Ml 21 $71.17 $22,981.39 $12,651.15 nat. median
$299

outlier · 42.4×
J9223
HCPCS
Lurbinectedin 4 Mg Inj 20 $197.79 $22,601.92 $12,566.68 nat. median
$619

outlier · 20.3×
J9311
HCPCS
Rituximab-hyaluron 1 400 Mg-23 400 Units/11.7 Ml Inj 21 $45.17 $22,236.47 $12,302.28 nat. median
$2,832

outlier · 4.3×
J3101
HCPCS
Tenecteplase 50 Mg/10 Ml Inj 21 $126.42 $21,781.70 $11,990.73 nat. median
$4,106

outlier · 2.9×
Q4100
HCPCS
Tissue Strattice 10 X 16 Firm 19 $3,773.66 $20,651.40 $11,709.56 nat. median
$1,907

outlier · 6.1×
J0491
HCPCS
Anifrolumab Fnia 300 Mg/2 Ml So 18 $6,622.13 $14,773.38 $11,090.02 nat. median
$74

outlier · 150.3×
J2323
HCPCS
Natalizumab 300 Mg/15 Ml Inj 21 $21.01 $24,261.49 $11,005.21 nat. median
$270

outlier · 40.8×
C9363
HCPCS
Graft Mesh Bilayer 2x2 Matrix 18 $5,780.77 $22,472.76 $10,706.51 nat. median
$1,436

outlier · 7.5×
J1300
HCPCS
Eculizumab 10 Mg/ml Inj 30 Ml 21 $230.32 $19,287.88 $10,617.89 nat. median
$704

outlier · 15.1×
J0896
HCPCS
Luspatercept 75 Mg Inj 20 $36.31 $33,642.26 $10,369.87 nat. median
$4,577

outlier · 2.3×
J9306
HCPCS
Pertuzumab 30 Mg/ml Inj 14 Ml 21 $13.91 $18,757.99 $10,326.18 nat. median
$91

outlier · 113.0×
J9309
HCPCS
Polatuzumab Vedotin 20 Mg/ml Inj 20 $126.92 $48,880.69 $9,724.03 nat. median
$4,537

outlier · 2.1×
37205
HCPCS
Transcath Ivasc Stent Perq Init Ves 37205 15 $6,044.22 $12,527.55 $9,686.25 nat. median
$5,968

1.6× median
Q4116
HCPCS
Tissue Alloderm 8 X 12 18 $5,476.68 $12,217.99 $9,171.75 nat. median
$500

outlier · 18.3×
J9271
HCPCS
Pembrolizumab 25 Mg/ml Inj 4 Ml 21 $55.91 $16,440.34 $9,050.33 nat. median
$326

outlier · 27.8×
J0517
HCPCS
Benralizumab 30 Mg/ml Inj 21 $171.30 $16,275.72 $8,959.71 nat. median
$966

outlier · 9.3×
J0717
HCPCS
Certolizumab 200 Mg/ml Inj 21 $8.18 $15,948.78 $8,779.73 nat. median
$1,767

outlier · 5.0×
J1290
HCPCS
Ecallantide 10 Mg/ml Inj 21 $492.44 $15,885.20 $8,744.73 nat. median
$867

outlier · 10.1×
J9354
HCPCS
Ado-trastuzumab Emtansine 20 Mg/ml Inj 5 Ml 21 $35.51 $17,727.55 $8,686.22 nat. median
$4,245

outlier · 2.0×
J2325
HCPCS
Nesiritide 1500 Mcg/5 Ml 21 $74.80 $15,630.23 $8,604.37 nat. median
$216

outlier · 39.7×
J2356
HCPCS
Tezepelumab 210 Mg/1.91 Ml Inj 18 $5,095.60 $11,367.84 $8,533.56 nat. median
$87

outlier · 98.0×
33916
HCPCS
Pulm Endartercomy W/bypass 33916 15 $5,264.06 $10,910.56 $8,436.00 nat. median
$4,712

1.8× median
J7189
HCPCS
Coagulation Factor Viia 1 000 Mcg/ml Inj 1 Ml 21 $2.23 $60,659.17 $8,356.69 nat. median
$3,661

outlier · 2.3×
33305
HCPCS
Repair Heart Wound W/bypass 33305 15 $5,094.18 $10,558.45 $8,163.75 nat. median
$5,031

1.6× median
J1640
HCPCS
Panhematin 7 Mg/ml Inj 21 $24.44 $14,788.67 $8,141.09 nat. median
$80

outlier · 101.5×

Other procedures at this hospital

Browse this hospital's 5,001 published procedures. Use the slice to choose what to show, then sort or filter any column.

Sortable, filterable data table. Use the column headers to sort, the filter row to narrow results.
Code Type Description Rate rows Payers Gross Cash Min $ Max $ Avg median Last observed
             
See an error in this hospital's data? Submit a correction